Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-17Clinical Trial Update: Study to Assess the Safety and Change in Disease Symptoms of Risankizumab (Skyrizi) in Adult Participants With Moderate to Severe Plaque Psoriasis and Psoriatic Arthritis
This clinical trial update reports safety findings and changes in disease symptoms for risankizumab (Skyrizi) in adults with moderate-to-sev…
-
CLINICAL_TRIALS trial_result · 2025-08-13Clinical Trial Update: Prediction Model for Osteopenia in Patients With Psoriasis
A completed study reports on a prediction model to assess osteopenia risk in patients with psoriasis.
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: Dermatologic Research Evaluation and Monitoring of Sleep in Moderate-to-Severe Psoriasis
A completed clinical trial evaluating sleep monitoring in adults with moderate-to-severe psoriasis, conducted by the University of Californi…
-
CLINICAL_TRIALS trial_result · 2025-08-03Clinical Trial Update: Immunogenetic Profiling of Goeckerman Therapy in the Treatment of Psoriasis Vulgaris [Phase 1]
An update on a Phase 1 trial studying immunogenetic profiling of Goeckerman Therapy for psoriasis vulgaris. The study status is terminated.
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Before and After Treatment
This completed study characterized lipoprotein composition and function in pediatric psoriasis patients before and after treatment to explor…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: Open Label Study of the Effects of Secukinumab on Nail Psoriasis and Non-Invasive Measures of Enthesitis (Phase IV) [Phase 4]
Open-label Phase IV study evaluating secukinumab for nail psoriasis and enthesitis in psoriasis patients has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: Rimegepant in Moderate Plaque-type Psoriasis [Phase 2]
Phase 2 study of rimegepant for moderate plaque-type psoriasis has completed. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: Topical Roflumilast to Treat Scalp and Body Psoriasis (ARRECTOR) [Phase 3]
Arcutis Biotherapeutics completed a Phase 3 trial of ARRECTOR (topical roflumilast) for scalp psoriasis, with results posted in July 2025.
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: A Clinical Trial of TQH3906 Capsules in Healthy Volunteers [Phase 1]
A Phase 1 study of TQH3906 capsules in healthy volunteers has completed, evaluating safety and pharmacokinetics for potential use in psorias…
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: A Clinical Evaluation of Marula-Derived Ceramide Cream on Skin Barrier Function Enhancement [NA]
A completed clinical trial evaluated the effect of a marula-derived ceramide cream on skin barrier function across several skin conditions, …
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: INulin-type Fructans-induced Gut Microbiota Modulation Impact on GUT-SKIN Axis Parameters in Psoriasis [NA]
A completed clinical trial evaluating whether INulin-type Fructans modulate gut microbiota and the gut-skin axis parameters in psoriasis.
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: A Study to Assess Deucravacitinib Post-marketing Surveillance in Participants With Psoriasis in Japan
A post-marketing surveillance study evaluating Deucravacitinib for psoriasis in Japan has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-02Clinical Trial Update: KX01 Ointment Phase 1 Study in Patients With Plaque Type Psoriasis [Phase 1]
This document reports the completion of a Phase 1 study evaluating KX01 Ointment in patients with psoriasis.
-
CLINICAL_TRIALS trial_result · 2025-07-02Clinical Trial Update: Assessing Patient Confidence in Biologic Medications [NA]
This is a completed clinical trial assessing patient confidence in biologic medications used for psoriasis. The sponsor is Wake Forest Unive…
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: The Impact of Untreated Depression and Anxiety Among Patients With Skin Diseases in Jeddah, Saudi Arabia.
This clinical trial update summarizes the impact of untreated depression and anxiety on patients with skin diseases in Jeddah, Saudi Arabia.…
-
CLINICAL_TRIALS trial_result · 2025-06-27Clinical Trial Update: Ten-Year Biologic Drug Survival in Psoriasis: Role of Genetic and Cardiometabolic Predictors
A completed clinical study evaluating ten-year persistence of biologic therapies in psoriasis and psoriatic arthritis and how genetic and ca…
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database
Completed safety and surveillance study of ustekinumab using the Ingenix NHI database in psoriasis. The update summarizes safety surveillanc…
-
CLINICAL_TRIALS trial_result · 2025-06-19Clinical Trial Update: Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Psoriasis)
Pfizer's infliximab biosimilar was studied in a Drug Use Investigation for psoriasis indications; the trial has completed and results were p…
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: Anti-Inflammatory Effects of Time-Restricted Feeding
A completed clinical trial update from NHLBI examining the anti-inflammatory effects of time-restricted feeding in psoriasis and systemic in…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Development and EValuation of an Online Intervention to Reduce Self-Stigma in People With Visible Chronic Skin disEases [NA]
A completed clinical trial conducted by Universitätsklinikum Hamburg-Eppendorf evaluating an online intervention to reduce self-stigma in pe…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Brain Changes in Psoriasis After Secukinumab Treatment [Phase 4]
Phase 4 trial results evaluating potential brain changes in psoriasis patients treated with secukinumab. Results were posted on 2025-06-05.
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis
Pfizer-sponsored trial of infliximab biosimilar 3 in rheumatoid arthritis, ulcerative colitis, Crohn's disease, and psoriasis has completed …
-
CLINICAL_TRIALS trial_result · 2025-05-25Clinical Trial Update: Mediterranean Diet vs no Dietary Intervention for Improving Signs and Symptoms of Psoriasis in Patients Treated With Anti-IL-17 or Anti-IL-23 Inhibitors [NA]
A clinical trial is evaluating whether a Mediterranean diet improves signs and symptoms of psoriasis in patients receiving anti-IL-17 or ant…
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: Randomized, Double-blind, Placebo-controlled Study of RSS0393 Ointment in Healthy and Psoriatic Subjects [Phase 1]
A Phase 1 randomized, double-blind, placebo-controlled study of RSS0393 ointment in healthy and psoriatic subjects is active but not recruit…
-
CLINICAL_TRIALS trial_result · 2025-05-01Clinical Trial Update: A Study Comparing the Risk of Serious Infections and Malignancies With Deucravacitinib or Biologics in Japanese Patients With Psoriasis
This clinical trial update describes a study comparing the risk of serious infections and malignancies between deucravacitinib and biologics…